Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Using injectable platelet-rich fibrin with bovine bone grafts to treat intrabony periodontal defects

Official title: Evaluation of the Effect of Injectable Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects With Xenogenic Grafts: a Randomized Controlled Clinical Trial

Run by Saglik Bilimleri Universitesi · NCT07146776 · Data updated 2026-11-12

This will try adding injectable platelet-rich fibrin (i-PRF) to bovine bone grafts to see if adults with stage III periodontitis and intrabony defects heal better than with grafts alone.

More Periodontitis trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment16 (estimated)
SponsorSaglik Bilimleri Universitesi
Academic / other
Locations1 site (Istanbul, Üsküdar)
StatusRecruiting
StartedJuly 12, 2025
Main results expectedDecember 1, 2026
Study endsDecember 30, 2026
Registry record updatedSeptember 11, 2026
Trial IDNCT07146776 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with stage III periodontitis who have interproximal 2- or 3-walled intrabony defects ≥3 mm and persistent probing depths ≥5 mm after initial therapy, and who are non-smokers or light smokers (≤10 cigarettes/day).

Probably not a fit

People with single-walled defects, uncontrolled systemic disease (such as uncontrolled diabetes), heavy smokers, those recently on antibiotics or with recent periodontal surgery, and pregnant or breastfeeding patients are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with stage III periodontitis and interproximal intrabony defects will undergo open flap debridement and receive either bovine-derived xenogenic bone graft mixed with i-PRF or the same graft mixed with saline. Clinical measures (for example probing pocket depth and defect area) and radiographic bone fill will be recorded and compared between the two groups. The aim is to determine whether i-PRF increases bone fill and reduces defect size versus graft alone. Findings will show whether adding this tissue-friendly biologic improves commonly used bovine xenograft outcomes for intrabony defects.

Why it matters

Potential benefit: If successful, adding i-PRF could increase bone fill and reduce pocket depths and defect size, improving periodontal healing after surgery.

How similar studies have gone: Previous studies combining PRF derivatives with various graft materials have shown promising results, but the specific combination of i-PRF with bovine-derived xenograft for intrabony defects has not been studied before.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and female patients aged 18-65 years
* Patients with Stage III Periodontitis according to the AAP-EFP 2017 Periodontal Disease Classification
* PPD≥5 mm (if persistent 6 weeks after initial periodontal treatment)
* Intrabony defects in the interproximal region with 2 or 3 walls and a depth of at least ≥3 mm
* Non-smokers (those who smoke up to 10 per day may be included)

Exclusion Criteria:

* Patients under 18 years of age or older than 65 years of age
* Patients unable to consent
* Systemic diseases that could affect the success of surgery, such as uncontrolled diabetes
* Single-walled intrabony defects
* Those who have taken antibiotics, anti-inflammatory or immunosuppressive drugs, or birth control pills within the three months prior to the study
* Those who have received active periodontal treatment within the last six months and periodontal surgery within the last year
* Smoking more than 10 cigarettes per day
* Pregnancy or breastfeeding
* Those taking medications that affect the gums (e.g., calcium channel blockers, phenytoin or cyclosporine)
* Teeth with furcation defects
* Those undergoing active orthodontic treatment
* Those who are allergic to the biomaterials used in the study or prescribed medications

Where it's running

  • Sağlık Bilimleri Üniversitesi
    Istanbul, Üsküdar, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.